Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Surgery|October 1, 1981
Management of carcinoma of anal canalT C Schneider, W J Schulte
Annals of Surgery|March 1, 1982
A re-evaluation of energy expenditure during parenteral nutritionE J Quebbeman, R K Ausman, T C Schneider
JPEN. Journal of Parenteral and Enteral Nutrition|January 1, 1986
The malfunctioning silastic catheter--radiologic assessment and treatmentT C Schneider, E Krzywda, D Andris, et al.
The Journal of Emergency Medicine|January 1, 1984
The relationship of the level of training and area of medical specialization with registrant performance in an advanced trauma life-support courseC Aprahamian, K T Nelson, B M Thompson, et al.
European Journal of Endocrinology|August 25, 2012
Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trialT C Schneider, R M Abdulrahman, E P Corssmit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2011
New treatment modalities in advanced thyroid cancerE Kapiteijn, T C Schneider, H Morreau, et al.
The Journal of Frailty & Aging|February 2, 2024
Reduced Handgrip Strength Is Associated with 1 Year-Mortality in Brazilian Frail Nonagenarians and CentenariansM L Sáez de Asteasu, E L Cadore, T Steffens, et al.
The Netherlands Journal of Medicine|November 13, 2014
To treat or not to treat: developments in the field of advanced differentiated thyroid cancerT C Schneider, E Kapiteijn, E P Corssmit, et al.
International Journal of Endocrinology|August 22, 2015
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II TrialT C Schneider, D de Wit, T P Links, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2016
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancerD de Wit, T C Schneider, D J A R Moes, et al.
Pageof 1